Literature DB >> 30762121

Clinicopathological characteristics associated with necrosis in pulmonary metastases from colorectal cancer.

Jun Suzuki1,2,3, Motohiro Kojima1, Keiju Aokage2, Takashi Sakai1,2, Hiroshi Nakamura1,3, Yuuki Ohara1,4, Kenta Tane2, Tomohiro Miyoshi2, Masato Sugano4, Satoshi Fujii1, Takeshi Kuwata4, Atsushi Ochiai5, Masaaki Ito6, Kenji Suzuki3, Masahiro Tsuboi2, Genichiro Ishii7.   

Abstract

Metastatic lung cancers from the colon and rectum (MLCR) frequently have necrotic components. The aim of this study is to elucidate clinicopathological factors associated with the amount of necrosis in MLCR. Ninety patients who underwent the first pulmonary metastasectomy for MLCR with a tumor diameter ≦ 3.0 cm and without chemotherapy were enrolled in this study. Analyzing digitally scanned pathological slides, we calculated the necrosis percentage (NP, the necrosis area divided by the tumor area). The relationship between NP and clinicopathological factors was analyzed. Moreover, to determine whether NP was affected by tissue hypoxia, vascularization, or tumor cell proliferation, tissues were analyzed by immunohistochemical staining using carbonic anhydrase IX (CAIX), CD34 antibodies, and Ki-67 antibodies, respectively. Median tumor area and NP were 0.69 cm2 (0.11-3.01) and 13.1% (0-71.6), respectively. Although NP was not associated with the tumor area, it was significantly higher in the patients with a positive smoking history (8.14% vs 17.1%, p = 0.045). Other clinicopathological factors were not correlated with NP. Immunohistochemical analysis revealed that CA IX expression on tumor cells, CD34 micro-vessel density, CD34 micro-vessel area, and Ki-67 index were not significantly associated with NP. NP in the primary site was not associated with NP in the pulmonary metastasis. NP was not determined by tumor size, tissue hypoxia, vascularization, or tumor cell proliferation. Positive correlation of NP with smoking history suggests a unique lung microenvironment in smokers which makes necrosis of MLCR more likely to occur.

Entities:  

Keywords:  Colorectal cancer; Necrosis; Pathology; Pulmonary metastasis

Mesh:

Substances:

Year:  2019        PMID: 30762121     DOI: 10.1007/s00428-019-02535-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

1.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

2.  Predictive factors of early outcome after palliative surgery for colorectal carcinoma.

Authors:  Ralf Konopke; Jörg Schubert; Oliver Stöltzing; Tina Thomas; Stephan Kersting; Axel Denz
Journal:  Innov Surg Sci       Date:  2020-11-02

Review 3.  Lactate dehydrogenase: a marker of diminished antitumor immunity.

Authors:  Sandra Van Wilpe; Rutger Koornstra; Martijn Den Brok; Jan Willem De Groot; Christian Blank; Jolanda De Vries; Winald Gerritsen; Niven Mehra
Journal:  Oncoimmunology       Date:  2020-02-26       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.